Recent Finacing
Recent Raise
RetiPharma develops neuroprotective peptide therapeutics for degenerative eye disorders using an in vivo translational platform, advancing intravitreal lead candidate RP001 toward clinical proof-of-concept for retinal detachment.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor